ResMed, Inc. First Quarter Earnings Sneak Peek

ResMed, Inc. (NYSE:RMD) will unveil its latest earnings on Monday, October 24, 2011. ResMed is a developer, manufacturer and distributor of medical equipment for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders.

ResMed, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 35 cents per share, a decline of 2.8% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. For the year, analysts are projecting profit of $1.54 per share, a rise of 5.5% from last year.

Last quarter, the company came in at net income of 39 cents per share against a mean estimate of profit of 36 cents per share, beating estimates after missing them in the previous quarter. In the third quarter of the last fiscal year, it missed forecasts by one cent.

Investing Insights: has a Stock Chart Technical Analysts Dream About.

Wall St. Revenue Expectations: Analysts are projecting a rise of 15.7% in revenue from the year-earlier quarter to $326.3 million.

Analyst Ratings: seven out of 11 analysts surveyed (63.6%) have a buy rating on ResMed.. This is below the mean analyst rating of nine competitors, which average 67.8% buy ratings.

A Look Back: In the fourth quarter of the last fiscal year, profit rose 10% to $58.5 million (37 cents a share) from $53.2 million (34 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 17.3% to $341.9 million from $291.6 million.

Key Stats:

The company has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. Over that span, the company has averaged growth of 13.8%, with the biggest boost coming in the most recent quarter when revenue rose 17.3% from the year earlier quarter.

The company has seen net income rise in three straight quarters. Net income rose 9.2% in the third quarter of the last fiscal year and 27.1% in the second quarter of the last fiscal year.

Competitors to Watch: Allied Healthcare Product (NASDAQ:AHPI), Masimo Corporation (NASDAQ:MASI), Electromed, Inc. (NASDAQ:ELMD), Medtronic, Inc. (NYSE:MDT), Dynatronics Corporation (NASDAQ:DYNT), Thermo Fisher Scientific Inc. (NYSE:TMO), Covidien plc (NYSE:COV), Dehaier Medical Systems Ltd (NASDAQ:DHRM), and CareFusion Corporation (NYSE:CFN).

Stock Price Performance: During August 22, 2011 to October 18, 2011, the stock price had risen $2.02 (7.2%) from $28.21 to $30.23. The stock price saw one of its best stretches over the last year between April 7, 2011 and April 21, 2011 when shares rose for 11-straight days, rising 7.9% (+$2.46) over that span. It saw one of its worst periods between July 19, 2011 and August 2, 2011 when shares fell for 11-straight days, falling 9.3% (-$3.02) over that span. Shares are down $4.41 (-12.7%) year to date.

(Source: Xignite Financials)

Investing Insights: has a Stock Chart Technical Analysts Dream About.